SERES THERAPEUTICS INC's ticker is MCRB and the CUSIP is 81750R102. A total of 94 filers reported holding SERES THERAPEUTICS INC in Q2 2016. The put-call ratio across all filers is 3.21 and the average weighting 0.8%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $3,000 | -25.0% | 1,000 | 0.0% | 0.00% | – |
| Q3 2019 | $4,000 | +33.3% | 1,000 | 0.0% | 0.00% | – |
| Q2 2019 | $3,000 | -57.1% | 1,000 | 0.0% | 0.00% | – |
| Q1 2019 | $7,000 | +40.0% | 1,000 | 0.0% | 0.00% | – |
| Q4 2018 | $5,000 | -81.5% | 1,000 | -71.4% | 0.00% | – |
| Q3 2018 | $27,000 | +145.5% | 3,500 | +133.3% | 0.00% | – |
| Q2 2018 | $11,000 | 0.0% | 1,500 | 0.0% | 0.00% | – |
| Q1 2018 | $11,000 | -57.7% | 1,500 | -42.3% | 0.00% | – |
| Q4 2017 | $26,000 | -23.5% | 2,600 | +23.8% | 0.00% | – |
| Q3 2017 | $34,000 | +61.9% | 2,100 | +10.5% | 0.00% | – |
| Q2 2017 | $21,000 | +110.0% | 1,900 | +111.1% | 0.00% | – |
| Q1 2017 | $10,000 | +11.1% | 900 | 0.0% | 0.00% | – |
| Q4 2016 | $9,000 | -18.2% | 900 | 0.0% | 0.00% | – |
| Q3 2016 | $11,000 | -8.3% | 900 | +125.0% | 0.00% | – |
| Q2 2016 | $12,000 | +50.0% | 400 | +33.3% | 0.00% | – |
| Q1 2016 | $8,000 | – | 300 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Flagship Pioneering Inc. | 23,117,045 | $148,411,000 | 6.25% |
| Eversept Partners, LP | 1,935,825 | $12,427,997 | 1.08% |
| Kynam Capital Management, LP | 772,820 | $4,962,000 | 1.05% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 366,493 | $2,353,000 | 0.80% |
| Lion Point Capital, LP | 626,803 | $3,228,000 | 0.71% |
| FEDERATED HERMES, INC. | 18,499,136 | $118,765,000 | 0.35% |
| Knott David M Jr | 110,000 | $706,000 | 0.30% |
| Atom Investors LP | 108,820 | $699,000 | 0.25% |
| Ikarian Capital, LLC | 131,310 | $843,000 | 0.17% |
| HARVARD MANAGEMENT CO INC | 131,847 | $846,000 | 0.10% |